Antibodies, Antineutrophil Cytoplasmic
"Antibodies, Antineutrophil Cytoplasmic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
MeSH Number(s)
D12.776.124.486.485.114.323.190
D12.776.124.790.651.114.323.190
D12.776.377.715.548.114.323.190
D23.101.050
Concept/Terms
Antibodies, Antineutrophil Cytoplasmic- Antibodies, Antineutrophil Cytoplasmic
- Antineutrophil Cytoplasmic Antibody
- Antibody, Antineutrophil Cytoplasmic
- Cytoplasmic Antibody, Antineutrophil
- Anti-Neutrophil Cytoplasmic Antibody
- Anti Neutrophil Cytoplasmic Antibody
- Antibody, Anti-Neutrophil Cytoplasmic
- Cytoplasmic Antibody, Anti-Neutrophil
- Anti-Neutrophil Cytoplasmic Antibodies
- Anti Neutrophil Cytoplasmic Antibodies
- Antibodies, Anti-Neutrophil Cytoplasmic
- Cytoplasmic Antibodies, Anti-Neutrophil
- ANCA
- Antineutrophil Cytoplasmic Antibodies
- Cytoplasmic Antibodies, Antineutrophil
Below are MeSH descriptors whose meaning is more general than "Antibodies, Antineutrophil Cytoplasmic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Antineutrophil Cytoplasmic".
This graph shows the total number of publications written about "Antibodies, Antineutrophil Cytoplasmic" by people in Harvard Catalyst Profiles by year, and whether "Antibodies, Antineutrophil Cytoplasmic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 0 | 3 | 3 |
1996 | 3 | 4 | 7 |
1997 | 3 | 2 | 5 |
1998 | 3 | 0 | 3 |
1999 | 2 | 0 | 2 |
2000 | 4 | 0 | 4 |
2001 | 2 | 1 | 3 |
2002 | 8 | 2 | 10 |
2003 | 5 | 0 | 5 |
2004 | 1 | 3 | 4 |
2005 | 5 | 2 | 7 |
2007 | 6 | 1 | 7 |
2008 | 3 | 1 | 4 |
2009 | 2 | 0 | 2 |
2010 | 0 | 3 | 3 |
2011 | 6 | 3 | 9 |
2012 | 1 | 2 | 3 |
2013 | 1 | 1 | 2 |
2014 | 1 | 2 | 3 |
2015 | 4 | 2 | 6 |
2016 | 4 | 1 | 5 |
2017 | 6 | 4 | 10 |
2018 | 2 | 2 | 4 |
2019 | 6 | 2 | 8 |
2020 | 6 | 2 | 8 |
2021 | 1 | 4 | 5 |
2022 | 1 | 7 | 8 |
2023 | 3 | 12 | 15 |
2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Antibodies, Antineutrophil Cytoplasmic" by people in Profiles.
-
Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024 Feb 17; 403(10427):683-698.
-
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial. Ann Rheum Dis. 2024 Feb 15; 83(3):351-359.
-
SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports. J Nephrol. 2024 Jan; 37(1):53-63.
-
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated Vasculitis. Arthritis Rheumatol. 2023 12; 75(12):2216-2227.
-
Imaging of Small Artery Vasculitis. Neuroimaging Clin N Am. 2024 Feb; 34(1):67-79.
-
Small fiber neuropathy associated with ANCA positivity: a case series and brief literature review. Neurol Sci. 2023 Dec; 44(12):4473-4479.
-
Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis. Lancet Rheumatol. 2023 Aug; 5(8):e483-e494.
-
Ocular manifestations of ANCA-associated vasculitis. Rheumatology (Oxford). 2023 07 05; 62(7):2517-2524.
-
Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality. Arthritis Rheumatol. 2023 09; 75(9):1599-1607.
-
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2023 Jun 30; 38(7):1655-1665.